Jiangsu Lianhuan Pharmaceutical Co., Ltd. announced that the board has approved the proposal to appoint Xia Chunlai as chair of sixth directorate, to nominate Pan Heping as director of sixth directorate and also approved to appoint Wu Wenge as general manager, at the special meeting of the sixth directorate held on December 28, 2016.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.16 CNY | -0.61% |
|
-1.45% | -26.75% |
06-20 | China Grants Active Pharmaceutical Ingredient Marketing Approval for Lianhuan Pharma's Cardiac Treatment | MT |
06-05 | China Approves Lianhuan Pharma's Prostate Cancer Tablets | MT |
1st Jan change | Capi. | |
---|---|---|
-26.75% | 321M | |
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |
- Stock Market
- Equities
- 600513 Stock
- News Jiangsu Lianhuan Pharmaceutical Co., Ltd.
- Jiangsu Lianhuan Pharmaceutical Co., Ltd. Announces Management Appointments